Alzheimer's Disease Clinical Trial at CCRStudies

 Adults under the age of 90 who have been diagnosed with mild or moderate Alzheimer’s disease, or undiagnosed individuals experiencing noticeable memory loss may be eligible to participate in a clinical trial for Alzheimer’s disease currently being conducted at CCRStudies in New London, Connecticut.  The study will include a free memory screening. 

This clinical trial research program, led by Dr. Laurence Radin of Neurological Group, PC in New London, is examining an investigational medication being developed to slow or halt the progression of Alzheimer’s disease.  Fellow researchers include Andrea Bartels APRN, and  Andrea Stewart APRN.  According to Dr. Radin, “this research will ideally bring us closer to a cure for Alzheimer’s, and will help to give hope to the individuals and families affected by Alzheimer's."   The trial is being sponsored by TauxRx Therapeutics.

More than five million Americans are currently living with Alzheimer’s disease and there is no cure.  Approximately 200,000 Americans under the age of 65 have younger onset Alzheimer’s.  Alzheimer’s is  a progressive, degenerative disorder that attacks the brains nerve cells, resulting in loss of memory, loss of thinking and language skills, and behavioral changes.

“People suffering from memory loss and those around them will tell you how devastating this disease can be,” said Dr. Radin.

CCRStudies is seeking volunteer participants for the current clinical trial.  Those who become eligible for the trial will receive study related care and psychological testing at no cost. Reimbursement for time and travel may be available.  No insurance is needed to participate in the clinical trial. 

For a preliminary phone evaluation, interested individuals can contact CCRStudies at 860-443-4567.  Those looking for more information can also visit www.ccrstudies.com.